NO995040L - 5-aryl-3-(8-azabicyklo(3.2.2)okt-3-yl)-1,3,4-oksadiazol-2(3H)- on-derivater som 5-HT4 reseptorligander - Google Patents

5-aryl-3-(8-azabicyklo(3.2.2)okt-3-yl)-1,3,4-oksadiazol-2(3H)- on-derivater som 5-HT4 reseptorligander

Info

Publication number
NO995040L
NO995040L NO995040A NO995040A NO995040L NO 995040 L NO995040 L NO 995040L NO 995040 A NO995040 A NO 995040A NO 995040 A NO995040 A NO 995040A NO 995040 L NO995040 L NO 995040L
Authority
NO
Norway
Prior art keywords
oxadiazol
azabicyclo
oct
aryl
derivatives
Prior art date
Application number
NO995040A
Other languages
English (en)
Norwegian (no)
Other versions
NO995040D0 (no
Inventor
Samir Jegham
Alistair Lochead
Frederic Galli
Alain Nedelec
Axelle Samson
Thierry Gallet
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO995040D0 publication Critical patent/NO995040D0/no
Publication of NO995040L publication Critical patent/NO995040L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO995040A 1997-04-18 1999-10-15 5-aryl-3-(8-azabicyklo(3.2.2)okt-3-yl)-1,3,4-oksadiazol-2(3H)- on-derivater som 5-HT4 reseptorligander NO995040L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9704802A FR2762316B1 (fr) 1997-04-18 1997-04-18 Derives de 5-aryl-3-(8-azabicyclo[3.2.1] octan-3-yl)-1,3,4- oxadiazol-2(3h)-one, leur preparation et leur application en therapeutique
PCT/FR1998/000754 WO1998047898A1 (fr) 1997-04-18 1998-04-15 Derives de 5-aryl-3-(8-azabicyclo(3.2.2)oct-3-yl)-1,3,4-oxadiazol-2(3h)-one en tant que ligands des recepteurs 5-ht4

Publications (2)

Publication Number Publication Date
NO995040D0 NO995040D0 (no) 1999-10-15
NO995040L true NO995040L (no) 1999-12-16

Family

ID=9506076

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995040A NO995040L (no) 1997-04-18 1999-10-15 5-aryl-3-(8-azabicyklo(3.2.2)okt-3-yl)-1,3,4-oksadiazol-2(3H)- on-derivater som 5-HT4 reseptorligander

Country Status (32)

Country Link
US (1) US6255319B1 (xx)
EP (1) EP0975631B1 (xx)
JP (1) JP2001521542A (xx)
KR (1) KR20010006452A (xx)
CN (1) CN1260794A (xx)
AR (1) AR012458A1 (xx)
AT (1) ATE206424T1 (xx)
AU (1) AU742666B2 (xx)
BG (1) BG64053B1 (xx)
BR (1) BR9808926A (xx)
CA (1) CA2286106A1 (xx)
CO (1) CO4750656A1 (xx)
CZ (1) CZ289154B6 (xx)
DE (1) DE69801905T2 (xx)
DK (1) DK0975631T3 (xx)
EE (1) EE03769B1 (xx)
ES (1) ES2165162T3 (xx)
FR (1) FR2762316B1 (xx)
HU (1) HUP0002456A3 (xx)
IL (1) IL132352A0 (xx)
NO (1) NO995040L (xx)
NZ (1) NZ500396A (xx)
PL (1) PL186894B1 (xx)
PT (1) PT975631E (xx)
RU (1) RU2186066C2 (xx)
SI (1) SI0975631T1 (xx)
SK (1) SK283441B6 (xx)
TR (1) TR199902600T2 (xx)
TW (1) TW502005B (xx)
UA (1) UA57071C2 (xx)
WO (1) WO1998047898A1 (xx)
ZA (1) ZA983257B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0211230D0 (en) * 2002-05-16 2002-06-26 Medinnova Sf Treatment of heart failure
AU2004226452B2 (en) * 2003-03-26 2008-07-24 Merck Sharp & Dohme Corp. Bicyclic piperidine derivatives as melanocortin-4 receptor agonists
JP2007511559A (ja) * 2003-11-18 2007-05-10 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 固形医薬製剤
WO2005123718A2 (en) 2004-06-15 2005-12-29 Pfizer Japan Inc. Benzimidazolone carboxylic acid derivatives
US7737163B2 (en) 2004-06-15 2010-06-15 Pfizer Inc. Benzimidazolone carboxylic acid derivatives
SE532388C2 (sv) * 2008-03-14 2010-01-12 Tetra Laval Holdings & Finance Förpackningslaminat och -behållare med två separata gasbarriärskikt samt metod för deras framställning
JP6348568B2 (ja) * 2013-03-15 2018-06-27 モンサント テクノロジー エルエルシー 線虫害虫防除のためのｎ−，ｃ−二置換アゾール
GB201814151D0 (en) * 2018-08-31 2018-10-17 Ucl Business Plc Compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2135414T3 (es) * 1991-09-12 1999-11-01 Smithkline Beecham Plc Antagonistas del receptor 5-ht4.
DE69319939T2 (de) * 1992-02-04 1999-02-18 Eisai Co., Ltd., Tokio/Tokyo Aminobenzoesäure Derivate
AU667874B2 (en) * 1992-02-06 1996-04-18 Smithkline Beecham Plc Benzopyran, benzothiopyran and benzofuran derivatives as 5-HT4 antagonists
JP3235913B2 (ja) * 1993-07-30 2001-12-04 エーザイ株式会社 アミノ安息香酸誘導体
SK282335B6 (sk) * 1995-11-09 2002-01-07 Sanofi-Synthelabo Deriváty 5-fenyl-3-(piperidin-4-yl)-1,3,4,-oxadiazol-2(3H)-ónu, spôsob ich prípravy a farmaceutický prostriedok, ktorý ich obsahuje

Also Published As

Publication number Publication date
SI0975631T1 (en) 2002-06-30
DE69801905D1 (de) 2001-11-08
EP0975631B1 (fr) 2001-10-04
PT975631E (pt) 2002-03-28
DK0975631T3 (da) 2002-01-28
AU742666B2 (en) 2002-01-10
CN1260794A (zh) 2000-07-19
JP2001521542A (ja) 2001-11-06
DE69801905T2 (de) 2002-07-04
FR2762316A1 (fr) 1998-10-23
BG103810A (en) 2000-06-30
ES2165162T3 (es) 2002-03-01
CZ289154B6 (cs) 2001-11-14
CZ364199A3 (cs) 2000-03-15
NO995040D0 (no) 1999-10-15
KR20010006452A (ko) 2001-01-26
UA57071C2 (uk) 2003-06-16
ZA983257B (en) 1998-10-19
BR9808926A (pt) 2000-08-01
EP0975631A1 (fr) 2000-02-02
AR012458A1 (es) 2000-10-18
ATE206424T1 (de) 2001-10-15
AU7341598A (en) 1998-11-13
PL186894B1 (pl) 2004-03-31
EE03769B1 (et) 2002-06-17
WO1998047898A1 (fr) 1998-10-29
FR2762316B1 (fr) 1999-12-17
BG64053B1 (bg) 2003-11-28
HUP0002456A2 (hu) 2000-12-28
IL132352A0 (en) 2001-03-19
RU2186066C2 (ru) 2002-07-27
SK283441B6 (sk) 2003-07-01
EE9900487A (et) 2000-06-15
NZ500396A (en) 2001-04-27
TR199902600T2 (xx) 2000-03-21
HUP0002456A3 (en) 2001-03-28
PL336315A1 (en) 2000-06-19
SK142699A3 (en) 2000-05-16
TW502005B (en) 2002-09-11
US6255319B1 (en) 2001-07-03
CO4750656A1 (es) 1999-03-31
CA2286106A1 (en) 1998-10-29

Similar Documents

Publication Publication Date Title
NO982092L (no) 5-fenyl-3-(piperidin-4-yl)-1,3,4-oksadiazol-2(3H)-on-derivater, for anvendelse som 5-HT4 eller H3 reseptorligander
MA26542A1 (fr) Derives oxindole substitues.
ZA9811473B (en) Arylpiperazines having activity at the serotonin 1A receptor.
HK1028399A1 (en) Cyclopentene derivatives useful as antagonists of the motilin receptor.
TR199802520A3 (tr) 1,3,8-Triaza-spiro(4,5) dekan -4-on türevleri.
NO995040L (no) 5-aryl-3-(8-azabicyklo(3.2.2)okt-3-yl)-1,3,4-oksadiazol-2(3H)- on-derivater som 5-HT4 reseptorligander
TR199901381A3 (tr) Diaza-spiro[3,5]nonan türevleri.
NO994106D0 (no) Oksazolidiner som 5-HT2A-antagonister
EP0681583A1 (en) TRICYCLIC HETEROCYCLIC COMPOUNDS AS 5-HT4 RECEPTOR ANTAGONISTS.
FI922903A0 (fi) 4-acetoxipiperidin derivat, deras framstaellningsfoerfarande och anvaendning som antagonist foer muskarina m-3 receptorer.
ZA963391B (en) Isoxazoline fibrinogen receptor antagonists.
NO943101D0 (no) 2,6-metano-2H-kinolizinderivat som 5-HT3-reseptorantagonist
DK1133494T3 (da) 8-Azabicyclo[3.2.1]oct-2-en-derivater
AU7658798A (en) 5-phenyl-1,3,4-oxadiazol-2(3h)-one derivatives and their use as 5-ht4 ligands
ZA9600758D (en) Idole derivatives as 5-ht receptor antagonist.
AU1449997A (en) Diazabicyclo-octane derivatives as 5-ht receptor ligands
AU2178299A (en) 8-azabicyclo(3.2.1)oct-2-ene derivatives as pesticides
ZA926890B (en) 5-HT4 receptor antagonists.
FI904279A0 (fi) Pyrido-(3,2,1-ij)-1,3,4 -benzoxadiazin-6-karboxylsyraderivat.
TR199700044U (tr) Renkli otomatik kase mekanizmasi.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application